First Rounders - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

First Rounders — Natural Sciences
First Rounders

Nature Biotechnology‘s First Rounders podcast is a series of conversations with founders, financers and developers from biotech’s past, present and future.

Hosted on Acast. See acast.com/privacy for more information.

Copyright: © 2019 Springer Nature 878632

Latest Episodes:

First Rounders: Samantha Du Oct 29, 2019

Show notes

Samantha Du is founder, CEO and chairman of Zai Lab. In her conversation with Nature Biotechnology she discusses her thoughts on the US-China trade war, what makes Zai Lab a success, and her family's experience during the Cultural Revolution in China.

Hosted on Acast. See acast.com/privacy for more information.

First Rounders: Pardis Sabeti Oct 01, 2019

Show notes

Pardis Sabeti is a co-founder of Sherlock Biosciences, the head of the Sabeti Lab, and a co-author of Outbreak Culture. Her conversation with Nature Biotechnology covers her family fleeing the Iranian revolution, the Sabeti Lab's role in the Ebola outbreak of 2014-2016, and the ATV accident that nearly killed her.

Hosted on Acast. See acast.com/privacy for more information.

First Rounders: Nina Tandon Aug 23, 2019

Show notes

Nina Tandon is co-founder and CEO of EpiBone. Her First Rounders conversation covers growing up on Roosevelt Island in New York City, witnessing September 11, and tackling her company's first Phase 1 trial.

Hosted on Acast. See acast.com/privacy for more information.

First Rounders: Cigall Kadoch Jul 01, 2019

Show notes

Cigall Kadoch is a co-founder of Foghorn Therapeutics and assistant professor at the Dana-Farber Cancer Institute, where she runs the Kadoch lab. In her talk with Nature Biotechnology, she discusses launching Foghorn, how geography affects biotech success, and the link between interior design and scientific rigor.

Hosted on Acast. See acast.com/privacy for more information.

First Rounders: Robert Langer May 07, 2019

Show notes

Robert Langer is the David H. Koch Institute professor at the Massachusetts Institute of Technology. He also runs the Langer Lab and is co-founder of more than 40 biotech companies. His talk with Nature Biotechnology covers the death of his father, his experience teaching high school science and math, and the requirements for launching a successful biotech.

Hosted on Acast. See acast.com/privacy for more information.

First Rounders: George Church Mar 01, 2019

Show notes

George Church is professor of genetics at Harvard University, and professor of health sciences and technology at Harvard and the Massachusetts Institute of Technology. He is also co-founder of more than 20 biotech companies. His talk with Nature Biotechnology covers being held back in 9th grade, launching the Human Genome Project, and the necessity of surveilling synthetic biologists.

Hosted on Acast. See acast.com/privacy for more information.

First Rounders: Chad Womack Jan 01, 2019

Show notes

Chad Womack is senior director of STEM initiatives at UNCF. The episode covers Womack's path to HIV research at Harvard, his experience founding a biotech just before the Great Recession, and what the election of President Barack Obama meant to African Americans.

Hosted on Acast. See acast.com/privacy for more information.

First Rounders: Christoph Lengauer Nov 01, 2018

Show notes

Christoph Lengauer is a venture partner at Third Rock Ventures, the president of Celsius Therapeutics, and executive vice president at Blueprint Medicines. His conversation with Nature Biotechnology covers growing up in Austria, why he nearly gave up research for a career helping settle refugees, and his role in the Henrietta Lacks story.

Hosted on Acast. See acast.com/privacy for more information.

First rounders: Feng Zhang Sep 06, 2018

Show notes

Feng Zhang runs the Zhang Lab at the Massachusetts Institute of Technology. He's also a faculty member at the Broad Institute of MIT and Harvard, and has co-founded several biotech companies, including Editas Medicine. His conversation with Nature Biotechnology covers immigrating to America as a boy, his moment of discovery with CRISPR, and what massive success before the age of 35 does to a researcher.

Hosted on Acast. See acast.com/privacy for more information.

First Rounder: John Maraganore May 07, 2018

Show notes

John Maraganore is CEO of Alnylam Pharmaceuticals. In his talk with Nature Biotechnology he discusses his decade at Biogen, running an RNAi company when skepticism covered the field, and growing up the son of Greek immigrants in Chicago.

Hosted on Acast. See acast.com/privacy for more information.

Related Podcasts